 |
-
Classic Value Investing: Antonio DeSpirito III, Pzena Investment Mgmt.
-
Investing in Biotechnology: Kurt von Emster, MPM Capital
-
Investing in Long-Term Quality Growth: John Thurston Beaty Jr., Beaty Haynes & Assoc.
-
Relative Value Sector Neutral Investing: Ben Friedman, RPF Equity Advisors
Topics covered: Large cap value stocks - Downside protection - Contrarian positioning - Biotech stocks - FDA approval trends - Wealth management services - Exchange traded funds (ETFs) - PEG ratios
Companies covered: Microsoft (MSFT), Magna (MGA), Lucent (LU), Johnson & Johnson (JNJ), Eli Lilly (LLY), ImClone (IMCL), Nektar (NKTR), Alkermes (ALKS), Favrille (FVRL), NitroMed (NTMD), CV Therapeutics (CVTX), General Electric (GE), Precision Drilling (PDS), Tyco (TYC), E*Trade (ET), Disney (DIS), Nordstrom (JWN), VF Corp. (VFC), Gardner Denver (GDI) and Old Dominion Freight Line (ODFL).
This Issue
costs $175 - and is non-returnable.
The Wall Street Transcript
does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call
(212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |